NCT06621758 · NOT YET RECRUITING

Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD

This study uses questionnaires to learn what people with mild cognitive impairment or subjective cognitive decline want to know during diagnostic counseling — and how they want that information delivered. It is not testing a drug or treatment. The phase is unspecified, which typically means this is observational research, not a clinical intervention trial.

Eligibility criteria

Inclusion Criteria:
* Diagnosed with SCD or MCI
* Lumbar puncture performed during the diagnostic process
* Age at or below 80 years
* MMSE at or above 24
Exclusion Criteria:
* Diagnosis of current major psychiatric disorder (schizophrenia, bipolar disorder, psychosis)
* Current excessive alcohol intake or substance abuse
Inclusion criteria for the co-participant:
* Attended the diagnostic disclosure visit together with the individual diagnosed with SCD or MCI

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-10-01

View full record on ClinicalTrials.gov

All APOE4 clinical trials